| Sampling variability of liver biopsy in nonalcoholic fatty liver disease V Ratziu, F Charlotte, A Heurtier, S Gombert, P Giral, E Bruckert, ... Gastroenterology 128 (7), 1898-1906, 2005 | 2439 | 2005 |
| Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study F Imbert-Bismut, V Ratziu, L Pieroni, F Charlotte, Y Benhamou, T Poynard The Lancet 357 (9262), 1069-1075, 2001 | 1988 | 2001 |
| Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients Y Benhamou, M Bochet, V Di Martino, F Charlotte, F Azria, A Coutellier, ... Hepatology 30 (4), 1054-1058, 1999 | 1634 | 1999 |
| Liver fibrosis in overweight patients V Ratziu, P Giral, F Charlotte, E Bruckert, V Thibault, I Theodorou, L Khalil, ... Gastroenterology 118 (6), 1117-1123, 2000 | 1368 | 2000 |
| Rates and risk factors of liver fibrosis progression in patients with chronic hepatitis C T Poynard, V Ratziu, F Charlotte, Z Goodman, J McHutchison, J Albrecht Journal of hepatology 34 (5), 730-739, 2001 | 1020 | 2001 |
| Extrahepatic manifestations of chronic hepatitis C P Cacoub, T Poynard, P Ghillani, F Charlotte, M Olivi, J Charles Piette, ... Arthritis & Rheumatism 42 (10), 2204-2212, 1999 | 949 | 1999 |
| Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) Trial V Ratziu, P Giral, S Jacqueminet, F Charlotte, A Hartemann–Heurtier, ... Gastroenterology 135 (1), 100-110, 2008 | 789 | 2008 |
| High prevalence of BRAF V600E mutations in Erdheim-Chester disease but not in other non-Langerhans cell histiocytoses J Haroche, F Charlotte, L Arnaud, A Von Deimling, Z Hélias-Rodzewicz, ... Blood 120 (13), 2700-2703, 2012 | 720 | 2012 |
| Dramatic efficacy of vemurafenib in both multisystemic and refractory Erdheim-Chester disease and Langerhans cell histiocytosis harboring the BRAF V600E mutation J Haroche, F Cohen-Aubart, JF Emile, L Arnaud, P Maksud, F Charlotte, ... Blood 121 (9), 1495-1500, 2013 | 656 | 2013 |
| Diagnostic value of biochemical markers (FibroTest-FibroSURE) for the prediction of liver fibrosis in patients with non-alcoholic fatty liver disease V Ratziu, J Massard, F Charlotte, D Messous, F Imbert-Bismut, L Bonyhay, ... BMC gastroenterology 6 (1), 6, 2006 | 653 | 2006 |
| A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver R Pais, F Charlotte, L Fedchuk, P Bedossa, P Lebray, T Poynard, V Ratziu Journal of hepatology 59 (3), 550-556, 2013 | 629 | 2013 |
| Recipient-type specific CD4< sup>+</sup> CD25< sup>+</sup> regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versus … A Trenado, F Charlotte, S Fisson, M Yagello, D Klatzmann, BL Salomon, ... The Journal of clinical investigation 112 (11), 1688-1696, 2003 | 622* | 2003 |
| Survival, liver failure, and hepatocellular carcinoma in obesity‐related cryptogenic cirrhosis V Ratziu, L Bonyhay, V Di Martino, F Charlotte, L Cavallaro, ... Hepatology 35 (6), 1485-1493, 2002 | 622 | 2002 |
| Hepatosplenic γδ T-cell lymphoma is a rare clinicopathologic entity with poor outcome: report on a series of 21 patients K Belhadj, F Reyes, JP Farcet, H Tilly, C Bastard, R Angonin, E Deconinck, ... Blood 102 (13), 4261-4269, 2003 | 526 | 2003 |
| The diagnostic value of biomarkers (SteatoTest) for the prediction of liver steatosis T Poynard, V Ratziu, S Naveau, D Thabut, F Charlotte, D Messous, ... Comparative hepatology 4 (1), 10, 2005 | 514 | 2005 |
| Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice M Sudres, F Norol, A Trenado, S Grégoire, F Charlotte, B Levacher, ... The Journal of Immunology 176 (12), 7761-7767, 2006 | 507 | 2006 |
| Prediction of liver histological lesions with biochemical markers in patients with chronic hepatitis B RP Myers, MH Tainturier, V Ratziu, A Piton, V Thibault, F Imbert-Bismut, ... Journal of hepatology 39 (2), 222-230, 2003 | 481 | 2003 |
| Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy C Besson, A Goubar, J Gabarre, W Rozenbaum, G Pialoux, FP Châtelet, ... Blood 98 (8), 2339-2344, 2001 | 472 | 2001 |
| Long‐term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial V Ratziu, F Charlotte, C Bernhardt, P Giral, M Halbron, G LeNaour, ... Hepatology 51 (2), 445-453, 2010 | 466 | 2010 |
| Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C T Poynard, M Munteanu, F Imbert-Bismut, F Charlotte, D Thabut, ... Clinical chemistry 50 (8), 1344-1355, 2004 | 462 | 2004 |
